The charges against Mr. Collins stem from his involvement with Innate Immunotherapeutics Limited, a drug maker based in Sydney, Australia, whose primary business was the research and development of a medication designed to treat a form of multiple sclerosis, according to an indictment.
Mr. Collins, 68, was attending the Congressional Picnic at the White House in June 2017 when he received a private email from the company’s chief executive that a test for a potentially lucrative experimental drug had failed, the indictment said. Fifteen minutes later, the congressman, who sat on the firm’s board of directors and was one of its largest shareholders, called his son, Cameron Collins, who sold his shares in the company, avoiding losses of more than $570,000, the indictment said. Mr. Collins did not sell his own shares, the indictment said.
“We will answer the charges filed against Congressman Collins in court and will mount a vigorous defense to clear his good name,” Mr. Collins’ lawyers, Jonathan Barr and Jonathan New, said in statement. “It is notable that even the government does not allege that Congressman Collins traded a single share” of the company’s stock.
The speaker of the House, Paul Ryan, stripped Mr. Collins of his seat on the Energy and Commerce Committee and called for the House Ethics Committee to look into the allegations. “Insider trading is a clear violation of the public trust,” Mr. Ryan said in a statement.
According to a federal indictment, Innate Immunotherapeutics’ chief executive, Simon Wilkinson, sent the email to the company’s board of directors, including Mr. Collins, at 6:55 p.m. on June 22, 2017, explaining that the test for the drug, known in its trial stage as MIS416, had failed.
[Read our January 2017 report on Innate Immunotherapies and its allies in Washington.]
Mr. Collins, prosecutors say, was attending the Congressional Picnic at the White House at the time. Fifteen minutes later, the indictment said, he wrote back to Mr. Wilkinson, saying, “Wow. Makes no sense. How are these results even possible???”
Read the Indictment Against Representative Chris CollinsPhone records included in the indictment show that Mr. Collins immediately called his son, missing him six times before they had a brief conversation. Prosecutors contend that it was during that conversation that Mr. Collins told his son about the failed drug test. The following morning, at 7:42 a.m., the indictment said, Cameron Collins placed an online order with his brokerage firm, selling more than 16,500 shares of Innate Immunotherapeutic stock.
Later that day, prosecutors said, Cameron Collins, 25, placed 17 more orders to sell the stock. Three days later, he placed an additional 36 sell orders. He also passed the tip on to others including his fiancée, who was not named in the indictment, and his fiancée’s father, Stephen Zarsky, 66, who was also charged.
On June 27, 2017, the day after Cameron Collins made his last trades selling Innate Immunotherapeutic stock, news of its failed drug test became public and the stock plummeted by more than 90 percent.
Prosecutors said that Representative Collins took steps to hide his involvement in the sale of the stock. For example, on June 28, 2017, one of his staff members issued a statement denying he had personally sold any shares and asserting his son had only sold shares after a halt on the trading of the stock had been lifted, a move that caused him “substantial financial loss.” Prosecutors said that the statement was “written in a manner designed to mislead the public.”
Mr. Collins was the first member of Congress to endorse Donald Trump, in February 2016, and that decision transformed him from a backbench member to one of the few lawmakers with any kind of relationship with the president after Mr. Trump won the White House that November.
Early in the Trump administration, he served as an informal liaison for the White House to Capitol Hill and would brag about how the president would call him on his cellphone unannounced.
His endorsement also helped make Mr. Collins a fixture on cable television, with numerous appearances on the CNN program of Chris Cuomo. There was a winking irony to those appearances, as Mr. Collins had long feuded with the host’s brother, Andrew M. Cuomo, the Democratic governor of New York. Mr. Collins said last year of the elder Mr. Cuomo, “You can’t believe anything this governor says.”
Mr. Cuomo pushed for his lieutenant governor, Kathy Hochul, to run against Mr. Collins this year instead of seeking re-election but Ms. Hochul has said she prefers her current role.
Mr. Collins first won the Buffalo-area seat in 2012, defeating Ms. Hochul. The 27th district is one of New York’s most conservative; it is where Mr. Trump won his highest percentage of vote in the state, with nearly 60 percent.
RELATED COVERAGE
Australian Drug Maker Has Low Profile but Powerful Backers in Washington Jan. 13, 2017
House Ethics Office Says New York Congressman May Have Violated Rules Oct. 12, 2017
If the G.O.P. Tax Plan Hurts You, Congressmen Say It’s Your State’s Fault Dec. 7, 2017
Get the full New York Times experience
.
